Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA4P2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,168
Award facts
- Contract value 100% obligated
- $61,168.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $61,168.25 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections. This firm fixed-price delivery order, issued on February 4, 2026, represents a non-competitive award under a larger Indefinite Delivery Contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of February 5, 2026. Dupixent is a biologic medication commonly prescribed for treating moderate-to-severe eczema, asthma, and chronic rhinosinusitis, making this procurement critical for supporting military and federal healthcare systems.
This delivery order is executed under AmerisourceBergen's substantial $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which extends through December 2026 and serves as the primary pharmaceutical supply vehicle for military healthcare programs globally. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., has demonstrated consistent capability in fulfilling federal pharmaceutical procurement requirements across diverse therapeutic domains. The non-set-aside award reflects AmerisourceBergen's competitive standing within the federal pharmaceutical distribution market and its role as a critical vendor supporting Defense Health Agency operations and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FA4P2?
SPE2DR26FA4P2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FA4P2 worth?
The government has obligated $61,168 on SPE2DR26FA4P2.
Is contract SPE2DR26FA4P2 an order under another contract?
Yes. SPE2DR26FA4P2 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA4P2 competed?
The extent of competition for SPE2DR26FA4P2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award